Related Experiment Video
Updated: May 11, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects
Iqra Rahat1, Pooja Yadav1, Aditi Singhal1
1Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut-250005, Uttar Pradesh, India.
Polymer lipid hybrid nanoparticles (PLHNPs) offer a promising solution for delivering plant-derived phytochemicals. These advanced nanocarriers improve the solubility, stability, and targeted delivery of phytochemicals, enhancing their therapeutic potential for various diseases.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Background:
- Phytochemicals exhibit diverse therapeutic properties but face delivery challenges like poor solubility and low bioavailability.
- Conventional delivery methods limit the clinical efficacy of plant-derived compounds.
Purpose of the Study:
- To review the potential of polymer lipid hybrid nanoparticles (PLHNPs) for enhanced phytochemical delivery.
- To explore PLHNPs as a strategy to overcome the limitations of traditional phytochemical administration.
Main Methods:
- Discussion of PLHNPs architecture, types, and surface modification strategies.
- Review of preclinical studies on phytochemical-loaded PLHNPs for disease management.
Main Results:
- PLHNPs improve encapsulation efficiency, stability, and controlled release of phytochemicals.
- Surface modifications enhance site-specific delivery and overall therapeutic efficacy.
- Preclinical data indicate efficacy in managing various diseases.
Conclusions:
- PLHNPs represent a potent delivery system for improving phytochemical bioavailability and therapeutic outcomes.
- Further research and development are needed for widespread clinical application of phytochemical-loaded PLHNPs.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Site-Targeted Drug Delivery Systems: Polymeric Carriers

